Good!!
Because many of the 300k soldiers with brain injuries are more likely to develop alzheimer’s.
I could probably use a batch in several years too!!!
"The results, reported on 31 August in Nature1, showed that aducanumab broke up amyloid-β proteins in patients with early-stage Alzheimers disease.
The trial mainly tested the safety of the drug in people, and so the final word on whether aducanumab works to ameliorate the memory and cognitive losses associated with Alzheimers
will have to wait until the completion of two larger phase III trials.
They are now in progress, and planned to run until at least 2020.